Company Profiles

driven by the PitchBook Platform

AsymmetRx Medical

Description

Developer of drug and medical devices. The company has developed p63 gene which is involved in the diagnosis of prostate cancer and many other cancers.

2001

Founded

PRIVATE

Status

Accelerator/Inc

Latest Deal Type

1

Investors

Description

Developer of drug and medical devices. The company has developed p63 gene which is involved in the diagnosis of prostate cancer and many other cancers.

Website:

www.asymmetrxmedical.com

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Other Industries

Other Devices and Supplies
Other Healthcare Services

Primary Office

100 Powder Mill Road Suite 177 Acton, MA 01720United States +1 (617) 799-2986
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AsymmetRx Medical's full profile, request a free trial.

    AsymmetRx Medical Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AsymmetRx Medical Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Fast Forward at Johns Hopkins UniversityAccelerator/Incubator000 0000000 0000
    Fast Forward at Johns Hopkins University Accelerator/Incubator

    AsymmetRx Medical Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Peter McKeonPresident & Board Member
    Frank McKeon Ph.DCo-Founder
    Matthew Vincent Ph.DCo-Founder
    Peter McKeon President & Board Member
    Frank McKeon Ph.D Co-Founder
    Matthew Vincent Ph.D Co-Founder

    AsymmetRx Medical Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Peter McKeonAsymmetRx MedicalPresident & Board Member000 0000
    Peter McKeon President & Board Member AsymmetRx Medical
    Request full access to PitchBook